Usa Mitchell Cancer Institute /ID# 276022

Mobile, Alabama 36604

1 studies enrolling now · 1 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant, Primary Peritoneal Cancer

Studies at this site

• A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. — Recruiting now